Shares of Futura Medical plc (LON:FUM – Get Free Report) were down 11.7% on Wednesday . The stock traded as low as GBX 0.53 and last traded at GBX 0.53. Approximately 3,180,240 shares changed hands during mid-day trading, a decline of 48% from the average daily volume of 6,068,521 shares. The stock had previously closed at GBX 0.60.
Futura Medical Stock Down 11.7%
The stock has a market capitalization of £3.08 million, a price-to-earnings ratio of -0.19 and a beta of 0.01. The stock’s 50-day simple moving average is GBX 0.87 and its 200 day simple moving average is GBX 1.09.
Futura Medical (LON:FUM – Get Free Report) last announced its earnings results on Wednesday, April 29th. The company reported GBX (2.78) EPS for the quarter. The business had revenue of GBX 170 million during the quarter. Futura Medical had a negative return on equity of 310.00% and a negative net margin of 534.62%. As a group, equities research analysts anticipate that Futura Medical plc will post 2.8486672 earnings per share for the current year.
Futura Medical Company Profile
Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.
Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.
Further Reading
- Five stocks we like better than Futura Medical
- Meta and Cloud Computing: Real Potential, or a Shot in the Dark?
- Insiders Are Selling These 3 Stocks—Should Investors Be Concerned?
- After SpaceX, Amazon Could Be The Next Best Space Stock
- 3 Stocks to Watch If the Strait of Hormuz Reopens
Receive News & Ratings for Futura Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Futura Medical and related companies with MarketBeat.com's FREE daily email newsletter.
